NCT03792880

Brief Summary

This clinical trial compares the usual follow-up to a program of telematic control and self-management in a group of patients with severe obstructive sleep apnea-hypopnea syndrome (OSAHS), few symptoms and treated with continuous positive airway pressure (CPAP). The objective of the intervention is to achieve a CPAP compliance of ≥4 hours per day in at least 90% of the subjects.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2019

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 12, 2018

Completed
3 months until next milestone

First Posted

Study publicly available on registry

January 4, 2019

Completed
5 months until next milestone

Study Start

First participant enrolled

June 1, 2019

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 28, 2020

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 28, 2021

Completed
Last Updated

April 26, 2022

Status Verified

April 1, 2022

Enrollment Period

1.6 years

First QC Date

October 12, 2018

Last Update Submit

April 25, 2022

Conditions

Keywords

CPAP treatmentSelf-management

Outcome Measures

Primary Outcomes (1)

  • Patients with a good CPAP compliance

    Percentage of patients with a CPAP compliance ≥4 hours per day. The main objective is to assess if a self-management and telematic control program can increase CPAP compliance getting at least 90% of patients using CPAP ≥4 hours per day.

    Six months

Secondary Outcomes (21)

  • CPAP compliance

    Six months

  • Dropout

    Six months

  • Side effects

    Six months

  • Efficacy of the treatment according to the change in sleepiness

    Six months

  • Efficacy of the treatment according to the change in the frequency of the snoring.

    Six months

  • +16 more secondary outcomes

Study Arms (2)

Control arm

ACTIVE COMPARATOR

Usual follow-up in Healthcare System for patients with obstructive sleep apnea and CPAP treatment

Behavioral: Habitual follow-up in Healthcare System

Intervention arm

EXPERIMENTAL

Usual follow-up in the Healthcare System for patients with obstructive sleep apnea and CPAP treatment and a telematic control and self-management program

Behavioral: Telematic control and self-management programBehavioral: Habitual follow-up in Healthcare System

Interventions

During 6 months with CPAP treatment, patients must complete some questionnaires about the presence of refreshing sleep and side effects with the frequency established, using a computing application. Patients can download this application on their own smartphone but, if they prefer, they can be provided with a tablet during the study with this application installed. A set of variables will be collected using an automatic and wireless transmission from latest generation CPAP to control the CPAP compliance and tolerance. All data will be processed in a platform to generate alarms, which will be controled daily by a researcher, as well as solutions to the problems presented during the monitoring.

Intervention arm

According to the SEPAR regulation, patients treated with CPAP should be evaluated by the pulmonologist one month after beginning treatment, every 3 months during the first year, every 6 months during the second year and annually from the third year.

Control armIntervention arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with a recent diagnostic of OSAHS with AHI≥ 30 and indication of CPAP.
  • Age≥ 18 years
  • Few symptoms, so that, without hypersomnolence (Epworth sleepiness scale ≤ 10)
  • Absence of clinic suspect or confirmation of other sleep pathology
  • With interest in the use of new technologies

You may not qualify if:

  • Nasal obstruction that prevents the use of CPAP
  • Psycho-physical inability to complete questionnaires and carry out the program
  • Patients undergoing uvulopalatopharyngoplasty
  • Cheyne-Stoke syndrome
  • Pregnancy
  • Absence of informed consent
  • Shift work in the last 3 months and transmeridian trips in the last month.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Virgen del Puerto Hospital

Plasencia, Cáceres, 10600, Spain

Location

San Pedro de Alcántara

Cáceres, 10003, Spain

Location

MeSH Terms

Conditions

Sleep Apnea, ObstructivePatient Compliance

Interventions

Self-ManagementDelivery of Health Care

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesPatient Acceptance of Health CareTreatment Adherence and ComplianceHealth BehaviorBehavior

Intervention Hierarchy (Ancestors)

RehabilitationHealth ServicesHealth Care Facilities Workforce and ServicesPatient Care ManagementHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • María Ángeles Sánchez Quiroga

    Virgen del Puerto Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized control trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 12, 2018

First Posted

January 4, 2019

Study Start

June 1, 2019

Primary Completion

December 28, 2020

Study Completion

December 28, 2021

Last Updated

April 26, 2022

Record last verified: 2022-04

Locations